Design a site like this with WordPress.com
Get started

~800 Covid-19 Vaccine Studies (Web-Based Google Spreadsheet)

I. Sources

ItemTitleAuthorPublicationDate PublishedURLArchive Link
Original Article Linking To Source“1000 Peer Reviewed Studies Questioning Covid-19 Vaccine Safety”None ListedInformed Choice Australia1/20/2022https://www.informedchoiceaustralia.com/post/1000-peer-reviewed-studies-questioning-covid-19-vaccine-safetyhttps://archive.is/G7iq0
Source PDF With Full List Of Studies & Definitions Of Side Effects ListedNone ListedN/A1/20/2022https://download-files.wixmp.com/ugd/b5e5d1_5941492af6e94bf0905dbabd83b91d5a.pdf?token=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJpc3MiOiJ1cm46YXBwOmU2NjYzMGU3MTRmMDQ5MGFhZWExZjE0OWIzYjY5ZTMyIiwic3ViIjoidXJuOmFwcDplNjY2MzBlNzE0ZjA0OTBhYWVhMWYxNDliM2I2OWUzMiIsImF1ZCI6WyJ1cm46c2VydmljZTpmaWxlLmRvd25sb2FkIl0sImlhdCI6MTY0NDY5Mjc4OCwiZXhwIjoxNjQ0NzI4Nzk4LCJqdGkiOiJkYmExODE0MzA4ZjgiLCJvYmoiOltbeyJwYXRoIjoiL3VnZC9iNWU1ZDFfNTk0MTQ5MmFmNmU5NGJmMDkwNWRiYWJkODNiOTFkNWEucGRmIn1dXSwiYXR0YWNobWVudCI6eyJmaWxlbmFtZSI6IlVwZGF0ZWRfUGVlcl9SZXZpZXdlZF9tZWRpY2FsX3BhcGVyc19zdWJtaXR0ZWRfdG9fdmFyaW91c19tZWRpY2FsLnBkZiJ9fQ.fNCjKPIsZMLV29kHuENp4_UtWD0afnq3UT_T-Kg_LxM
Cited By“HERE’S THE LIST: 1,000 Different Studies Show Extensive Evidence of COVID-19 Vaccines Adverse Events”Jim HoftGateway Pundit2/9/2022https://www.thegatewaypundit.com/2022/02/list-1000-different-studies-show-extensive-evidence-covid-19-vaccines-adverse-events/https://ar

II. Notes

Notes For The Reviewer
I. Quantity of Research Listed
1. The preponderance of studies does not in and of itself suggest an overwhelming amount of evidence concerning side effects. It is up to the reader to review each one individually and draw their own conclusions.
2. The same study may be published as two different articles, or a variation of a single study may be published twice. This was not assessed in compiling the list.
II. De-Duplication – Potential Errors
2. The entries have been de-duplicated in an automated fashion. Some non-duplicative links may have been removed in error.
3. In the de-duplication process, studies which crossed multiple categories will only be listed once. As a result, the significance of a side effect in a particular category may erroneously appear to be reduced.
III. Archive Link For This Spreadsheet
https://archive.is/3QsOR

III. Data

Access Online Spreadsheet: Click here.

View contents of spreadsheet: See below.

CategoryTitleURL
Acute Coronary SyndromeMrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testinghttps://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
Acute Eosinophilic PneumoniaAcute eosinophilic pneumonia associated with anti-COVID-19 vaccine AZD1222https://pubmed.ncbi.nlm.nih.gov/34812326/
Acute Hemichorea-HemibalismusAcute hemichorea-hemibalismus after COVID-19 (AZD1222) vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34581453/
Acute Hyperactive EncephalopathyAcute disseminated encephalomyelitis following vaccination against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34325334/
Acute Hyperactive EncephalopathyAcute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolonehttps://www.sciencedirect.com/science/article/pii/S2049080121007536
Acute Hyperactive EncephalopathyPost-vaccinal encephalitis after ChAdOxnCov-19https://pubmed.ncbi.nlm.nih.gov/34324214/
Acute Inflammatory NeuropathiesReporting of acute inflammatory neuropathies with COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34579259/
Acute Kidney InjuryAcute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34352309/
Acute Kidney InjurySystemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34362727/
Acute Kidney InjuryMinimal change disease and acute kidney injury after Pfizer-BioNTech COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34000278/
Acute Kidney InjuryMinimal change disease with severe acute kidney injury after Oxford-AstraZeneca COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34242687/
Acute lympholysisRituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34429981/
Acute Macular NeuroretinopathyBilateral acute macular neuroretinopathy after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34287612/
Acute MyelitisA case of longitudinally extensive transverse myelitis following Covid-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34182207/
Acute MyelitisAcute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34131771/
Acute MyelitisAcute myelitis and ChAdOxnCoV-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S0165572821002137
Acute MyelitisAcute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)



https://pubmed.ncbi.nlm.nih.gov/33981305/
Acute MyelitisAcute transverse myelitis after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34482455/
Acute MyelitisAcute transverse myelitis following inactivated COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34370410/
Acute MyelitisExtensive longitudinal transverse myelitis after ChAdOxnCOV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34641797/
Acute MyelitisExtensive longitudinal transverse myelitis following AstraZeneca COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34507942/
Acute MyelitisLongitudinally extensive cervical myelitis after vaccination with inactivated virus based COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34849183/
Acute MyelitisPost COVID-19 transverse myelitis; a with review of the literaturehttps://pubmed.ncbi.nlm.nih.gov/34457267/
Allergic ReactionsAllergenic components of the mRNA-127vaccine for COVID-19https://pubmed.ncbi.nlm.nih.gov/33657648/
Allergic ReactionsAllergic reactions after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34463751/
Allergic ReactionsAllergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experiencehttps://pubmed.ncbi.nlm.nih.gov/34474708/
Allergic ReactionsAllergic reactions to COVID-19 vaccineshttps://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447
Allergic ReactionsAllergic reactions to the first COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33320974/
Allergic ReactionsAn academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy historyhttps://www.sciencedirect.com/science/article/pii/S2213219821007972
Allergic ReactionsAssessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open, 4(9), e21255doihttps://www.ncbi.nlm.nih.gov/pubmed/34533570
Allergic ReactionsAssociation of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34698847/
Allergic ReactionsPfizer Vaccine Raises Allergy Concernshttps://pubmed.ncbi.nlm.nih.gov/33384356/
Allergic ReactionsPolyethylene glycole allergy of the SARS CoVvaccine recipienthttps://pubmed.ncbi.nlm.nih.gov/33919151/
Allergic ReactionsRisk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseasehttps://pubmed.ncbi.nlm.nih.gov/33752263/
Allergic ReactionsSevere Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USAhttps://pubmed.ncbi.nlm.nih.gov/33643776/
Allergic ReactionsSevere allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USAhttps://www.ncbi.nlm.nih.gov/pubmed/33643776
Allergic ReactionsAcute Allergic Reactions to mRNA COVID-19 Vaccineshttps://pubmed.ncbi.nlm.nih.gov/33683290/
Alopecia AreataRecurrence of alopecia areata after covid-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34741583/
Amyotrophic NeuralgiaAmyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) COVID-19https://pubmed.ncbi.nlm.nih.gov/34330677/
Anaphylaxis.IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/34318537/
AnaphylaxisAllergic reactions and anaphylaxis to LNP-based COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/33571463/
AnaphylaxisAllergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – United States, December 14-23, 20 MMWR Morb Mortal Wkly Rep, 70(2), 46-doihttps://www.ncbi.nlm.nih.gov/pubmed/33444297
AnaphylaxisAllergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine – United States, December 21, 2020-January 10, 2021https://pubmed.ncbi.nlm.nih.gov/33507892/
AnaphylaxisAllergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine – United States, December 21, 2020 to January 10, 2021https://pubmed.ncbi.nlm.nih.gov/33641268/
AnaphylaxisAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer BioNTech COVID-19 vaccine – United States, December 14-23, 2020https://pubmed.ncbi.nlm.nih.gov/33444297/
AnaphylaxisAllergic reactions, including anaphylaxis, after receiving the first dose of Pfizer BioNTech COVID-19 vaccine – United States, December 1to 23, 2020https://pubmed.ncbi.nlm.nih.gov/33641264/
AnaphylaxisAllergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer BioNTech COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33475702/
AnaphylaxisAnaphylactic reactions to COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/33846043/188
AnaphylaxisAnaphylaxis after Modern COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34734159/
AnaphylaxisAnaphylaxis Associated with COVID-19 mRNA Vaccineshttps://pubmed.ncbi.nlm.nih.gov/33932618/
AnaphylaxisAnaphylaxis following Covid-19 vaccine in a patient with cholinergic urticariahttps://pubmed.ncbi.nlm.nih.gov/33851711/
AnaphylaxisAnaphylaxis induced by CoronaVac COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34675550/
AnaphylaxisAnaphylaxis reactions to Pfizer BNT162bvaccinehttps://pubmed.ncbi.nlm.nih.gov/34579211/
AnaphylaxisBiphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19https://pubmed.ncbi.nlm.nih.gov/34050949/
AnaphylaxisBiphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test resulthttps://pubmed.ncbi.nlm.nih.gov/34343674/
AnaphylaxisCOVID-19 vaccine-associated anaphylaxishttps://www.sciencedirect.com/science/article/pii/S1939455121000119.
AnaphylaxisCumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japanhttps://pubmed.ncbi.nlm.nih.gov/34347278/
AnaphylaxisCumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japanhttps://www.ncbi.nlm.nih.gov/pubmed/34347278
AnaphylaxisElevated rates of anaphylaxis after vaccination with Pfizer BNT162bmRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety datahttps://pubmed.ncbi.nlm.nih.gov/34128049/
AnaphylaxisImmunization practices and risk of anaphylaxishttps://pubmed.ncbi.nlm.nih.gov/34269740/
AnaphylaxisPolyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33825239/
AnaphylaxisProlonged anaphylaxis to Pfizer 2019 coronavirus disease vaccinehttps://pubmed.ncbi.nlm.nih.gov/33834172/
AnaphylaxisRelationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34215453/
AnaphylaxisReports of anaphylaxis after coronavirus disease vaccination 2019, South Korea, February 26-April 30, 2021https://pubmed.ncbi.nlm.nih.gov/34414880/
AnaphylaxisReports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021https://pubmed.ncbi.nlm.nih.gov/33576785/
AnaphylaxisSex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19https://pubmed.ncbi.nlm.nih.gov/34020815/
ANCA GlomerulonephritisANCA glomerulonephritis following Modern COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34081948/
Angioimmunoblastic T-cell LymphomaRapid progression of angioimmunoblastic T-cell lymphoma after BNT162bmRNA booster vaccinationhttps://www.frontiersin.org/articles/10.3389/fmed.2021.798095/
ArthritisReactive arthritis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34033732/
AsthmaCOVID vaccination and asthma exacerbationhttps://www.ncbi.nlm.nih.gov/pubmed/34547487
Axillary adenopathyAdenopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33625299/
Axillary adenopathyAxillary adenopathy associated with COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33624520/
Axillary adenopathyAxillary lymphadenopathy in patients with recent Covid-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34825530/
Axillary adenopathyCOVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PEThttps://www.sciencedirect.com/science/article/pii/S1930043321002612
Axillary adenopathyCOVID-19 vaccine-induced unilateral axillary adenopathyhttps://pubmed.ncbi.nlm.nih.gov/34655312/
Axillary adenopathyCOVID-19 vaccine-related axillary lymphadenopathy in breast cancer patientshttps://pubmed.ncbi.nlm.nih.gov/34836672/
Axillary adenopathyEvolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34735411/
Axillary adenopathyIncidence of axillary adenopathy on breast imaging after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34292295/
Axillary adenopathySubclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammographyhttps://pubmed.ncbi.nlm.nih.gov/34906409/
Axillary adenopathyUnilateral axillary adenopathy in the setting of COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34298342/
Axillary adenopathyUnilateral axillary lymphadenopathy related to COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34325221/
Bell’s PalsyA case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34272622/
Bell’s PalsyAcute facial paralysis as a possible complication of SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33975372/
Bell’s PalsyAdverse event reporting and risk of Bell’s palsy after COVID-19 vaccinationhttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.
Bell’s PalsyBell’s palsy after 2hours of mRNA-127SARS-CoV-mRNA-127vaccinehttps://pubmed.ncbi.nlm.nih.gov/34336436/
Bell’s PalsyBell’s palsy after a single dose of vaccine mRNA. SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34032902/
Bell’s PalsyBell’s palsy after COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S217358082100122X.
Bell’s PalsyBell’s palsy after COVID-19 vaccination with high antibody response in CSFhttps://pubmed.ncbi.nlm.nih.gov/34322761/
Bell’s PalsyBell’s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell’s palsyhttps://pubmed.ncbi.nlm.nih.gov/34621891/
Bell’s PalsyBell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsyhttps://www.sciencedirect.com/science/article/pii/S266635462100020X
Bell’s PalsyBell’s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-vaccineshttps://pubmed.ncbi.nlm.nih.gov/34411532/
Bell’s PalsyBilateral facial nerve palsy and COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34522557/
Bell’s PalsyLeft Bell’s palsy after the first dose of mRNA-127SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34763263/
Bell’s PalsyThe association between COVID-19 vaccination and Bell’s palsyhttps://pubmed.ncbi.nlm.nih.gov/34411533/
Bell’s PalsyType I interferons as a potential mechanism linking COVID-19 mRNA vaccines with Bell’s palsyhttps://pubmed.ncbi.nlm.nih.gov/33858693/
Bleeding episodesAssociation between ChAdOxnCoV-19 vaccination and bleeding episodeshttps://pubmed.ncbi.nlm.nih.gov/34479760/
Bleeding episodesBlood clots and bleeding episodes after BNT162band ChAdOxnCoV-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0896841121000937
Blood ClotsBlood clots and bleeding after BNT162band ChAdOxnCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34174723/
Brain DeathBrain death in a vaccinated patient with COVID-19 infectionhttps://pubmed.ncbi.nlm.nih.gov/34656887/
Brain Haemorrhage (Includes TermFatal brain haemorrhage after COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33928772/
Bullous Drug EruptionBullous drug eruption after the second dose of COVID-19 mRNA-127(Moderna) vaccinehttps://www.sciencedirect.com/science/article/pii/S1876034121001878.
Bullous Drug EruptionWidespread fixed bullous drug eruption after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34482558/
Capillary Leak Syndrome (Includes TermFatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myelomahttps://pubmed.ncbi.nlm.nih.gov/34459725/
CardiacA review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doihttps://www.ncbi.nlm.nih.gov/pubmed/34808708
CardiacCardiac complications following mRNA COVID-19 vaccineshttps://www.ncbi.nlm.nih.gov/pubmed/34921468
CardiacTemporal relationship between the second dose of BNT162bmRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-infectionhttps://www.sciencedirect.com/science/article/pii/S2352906721000622
CardiacTransient cardiac injury in adolescents receiving the BNT162bmRNA COVID-19 vaccinehttps://journals.lww.com/pidj/Abstract/9000/
CardiacTransient Cardiac Injury in Adolescents Receiving the BNT162bmRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e3 doihttps://www.ncbi.nlm.nih.gov/pubmed/34077949
Cardiovascular eventsBe alert to the risk of adverse cardiovascular events after COVID-19 vaccinationhttps://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033
Cardiovascular EventsCardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOxnCoV-19, and Ad2COVS vaccineshttps://pubmed.ncbi.nlm.nih.gov/34710832/
Central Serous RetinopathyAcute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccinehttps://www.sciencedirect.com/science/article/pii/S2451993621001456.
Central Vein OcclusionCentral retinal vein occlusion after vaccination with SARS-CoV-mRNAhttps://pubmed.ncbi.nlm.nih.gov/34571653/
Cerebral Venous ThrombosisA rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34274191/
Cerebral Venous ThrombosisA rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0735675721005714
Cerebral Venous ThrombosisA rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33917902/
Cerebral Venous ThrombosisAcute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34247246/
Cerebral Venous ThrombosisAdverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)https://pubmed.ncbi.nlm.nih.gov/34092166/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis after ChAdOxnCov-19 vaccination with a misleading first brain MRIhttps://pubmed.ncbi.nlm.nih.gov/34244448/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis after vaccinationhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext
Cerebral Venous ThrombosisCerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33845870/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34333995/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis following vaccination against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34293217/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis in the U.S. population after SARS-CoV- vaccination with adenovirus and after COVID-19https://www.sciencedirect.com/science/article/pii/S0735109721051949
Cerebral Venous ThrombosisCerebral venous sinus thrombosis in the U.S. population, After SARS-CoV- vaccination with adenovirus and after COVID-19https://pubmed.ncbi.nlm.nih.gov/34116145/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis negative for anti-PFantibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulationhttps://www.sciencedirect.com/science/article/pii/S1871402121002046
Cerebral Venous ThrombosisCerebral venous sinus thrombosis weeks after first dose of SARS-CoV-mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34101024/
Cerebral Venous ThrombosisCerebral venous sinus thrombosis weeks after the first dose of SARS-CoV- mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34101024/
Cerebral Venous ThrombosisCerebral venous thrombosis after BNT162bmRNA SARS-CoV-vaccinehttps://www.sciencedirect.com/science/article/abs/pii/S1052305721003098
Cerebral Venous ThrombosisCerebral venous thrombosis after the BNT162bmRNA SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34111775/
Cerebral Venous ThrombosisCerebral venous thrombosis and myeloproliferative neoplasmshttps://pubmed.ncbi.nlm.nih.gov/34453762/
Cerebral Venous ThrombosisCerebral venous thrombosis and thrombocytopenia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33878469/
Cerebral Venous ThrombosisCerebral venous thrombosis associated with COVID-19 vaccine in Germanyhttps://pubmed.ncbi.nlm.nih.gov/34288044/
Cerebral Venous ThrombosisCerebral venous thrombosis associated with the covid-19 vaccine in Germanyhttps://onlinelibrary.wiley.com/doi/10.1002/ana.26172
Cerebral Venous ThrombosisCerebral venous thrombosis developing after vaccination. COVID-19https://pubmed.ncbi.nlm.nih.gov/34695859/
Cerebral Venous ThrombosisCerebral venous thrombosis following BNT162bmRNA vaccination of BNT162b against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34133027/
Cerebral Venous ThrombosisCerebral venous thrombosis following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34045111/
Cerebral Venous ThrombosisCerebral venous thrombosis induced by SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34090750/
Cerebral Venous ThrombosisCOVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33863748/
Cerebral Venous ThrombosisDeep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV- mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/33687691/
Cerebral Venous ThrombosisDiagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/33914590/
Cerebral Venous ThrombosisDiagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0213485321000839
Cerebral Venous ThrombosisLethal cerebral venous sinus thrombosis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33983464/
Cerebral Venous ThrombosisMassive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19https://pubmed.ncbi.nlm.nih.gov/34373991/
Cerebral Venous ThrombosisMassive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34261296/
Cerebral Venous ThrombosisThe importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34001390/
Cerebral Venous ThrombosisVaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford AstraZeneca COVID-19https://www.sciencedirect.com/science/article/pii/S235255682100093X
Cerebral Venous ThrombosisVaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality ratehttps://pubmed.ncbi.nlm.nih.gov/34393988/
Cerebral Venous ThrombosisVenous sinus thrombosis after vaccination with ChAdOxnCov-19https://pubmed.ncbi.nlm.nih.gov/34420802/
Chest PainChest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Modernahttps://pubmed.ncbi.nlm.nih.gov/34866106/
CNS DemyelinationA systematic review of cases of CNS demyelination following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34839149/
CNS InflammationCOVID-19 mRNA vaccine causing CNS inflammationhttps://link.springer.com/article/10.1007/s00415-021-10780-7
CoagulopathiesCoagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathwayshttps://pubmed.ncbi.nlm.nih.gov/34639132/
Cutaneous Adverse EffectsCutaneous adverse effects of available COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34518015/
Cutaneous Adverse EffectsCutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19https://pubmed.ncbi.nlm.nih.gov/34661934/
Cutaneous Adverse EffectsRare cutaneous adverse effects of COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34363637/
Cutaneous ReactionsLate cutaneous reactions after administration of COVID-19 mRNA vaccineshttps://www.sciencedirect.com/science/article/pii/S2213219821007996
DepressionDepression after ChAdOx1-S / nCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34608345/
Eosinophilic DermatosisEosinophilic dermatosis after AstraZeneca COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34753210/
Facial Nerve PalsyCOVID-19 vaccination association and facial nerve palsyhttps://pubmed.ncbi.nlm.nih.gov/34165512/
Facial Nerve PalsyFacial nerve palsy after administration of COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/34492394/
Facial Nerve PalsyFacial nerve palsy following administration of COVID-19 mRNA vaccineshttps://www.sciencedirect.com/science/article/pii/S1201971221007049
Facial Nerve PalsyPeripheral facial nerve palsy after vaccination with BNT162b(COVID-19)https://pubmed.ncbi.nlm.nih.gov/33734623/
Facial Nerve PalsySequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34281950/
GastroparesisGastroparesis after Pfizer-BioNTech COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34187985/
Graves’ DiseaseTwo cases of Graves’ disease after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33858208/
Gross HematuriaGross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropatyhttps://pubmed.ncbi.nlm.nih.gov/33771584/
Guillain-Barré syndromeA case of Guillain-Barré syndrome after Pfizer COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34567447/
Guillain-Barré syndromeA case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM antibodies after first dose of COVID-19 BNT162bmRNA vaccine (Pfizer)https://pubmed.ncbi.nlm.nih.gov/34871447/
Guillain-Barré syndromeA novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19https://pubmed.ncbi.nlm.nih.gov/34449715/
Guillain-Barré syndromeA rare case of Guillain-Barré syndrome after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34671572/
Guillain-Barré syndromeA rare variant of Guillain-Barré syndrome after vaccination with Ad2COVShttps://pubmed.ncbi.nlm.nih.gov/34703690/
Guillain-Barré syndromeA variant of Guillain-Barré syndrome after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34370408/
Guillain-Barré syndromeAssociation of receipt association of Ad2COVS COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021https://jamanetwork.com/journals/jama/fullarticle/2785009
Guillain-Barré syndromeAstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmaniahttps://pubmed.ncbi.nlm.nih.gov/34560365/
Guillain-Barré syndromeBilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34261746/
Guillain-Barré syndromeClinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccinehttps://pubmed.ncbi.nlm.nih.gov/34808658/
Guillain-Barré syndromeCOVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsyhttps://onlinelibrary.wiley.com/doi/10.1002/ana.26258.
Guillain-Barré syndromeCOVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effecthttps://pubmed.ncbi.nlm.nih.gov/34484780/
Guillain-Barré syndromeCOVID-19, Guillain-Barré and vaccineA dangerous mixhttps://pubmed.ncbi.nlm.nih.gov/34108736/
Guillain-Barré syndromeFacial diplegiahttps://pubmed.ncbi.nlm.nih.gov/34447646/
Guillain-Barré syndromeGMganglioside antibody and COVID-19-related Guillain Barre syndromehttps://www.sciencedirect.com/science/article/pii/S2666354621000065
Guillain-Barré syndromeGuillain-Barré syndrome after AstraZeneca COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0303846721004169
Guillain-Barré syndromeGuillain-Barre syndrome after BNT162bCOVID-19 vaccinehttps://link.springer.com/article/10.1007%2Fs10072-021-05523-5.
Guillain-Barré syndromeGuillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34114256/
Guillain-Barré syndromeGuillain-Barré syndrome after ChAdOxnCoV-19 COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34548920/
Guillain-Barré syndromeGuillain-Barre syndrome after COVID-19 mRNA-127vaccinehttps://pubmed.ncbi.nlm.nih.gov/34767184/
Guillain-Barré syndromeGuillain-Barre syndrome after COVID-19 vaccination in an adolescenthttps://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.
Guillain-Barré syndromeGuillain-Barré syndrome after SARS-CoV-vaccination in a patient with previous vaccine-associated Guillain-Barré syndromehttps://pubmed.ncbi.nlm.nih.gov/34810163/
Guillain-Barré syndromeGuillain-Barre syndrome after the first dose of COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34779385/
Guillain-Barré syndromeGuillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34796417/
Guillain-Barré syndromeGuillain-Barre syndrome after the first dose of SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/33968610/
Guillain-Barré syndromeGuillain-Barré syndrome after the first dose of SARS-CoV-vaccinehttps://www.sciencedirect.com/science/article/pii/S2214250921000998.
Guillain-Barré syndromeGuillain-Barre syndrome after the first injection of ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34217513/
Guillain-Barré syndromeGuillain-Barré syndrome after the first injection of ChAdOxnCoV-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S0035378721005853.
Guillain-Barré syndromeGuillain-Barré syndrome associated with COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34648420/
Guillain-Barré syndromeGuillain-Barre syndrome following SARS-CoV-vaccination in 19 patientshttps://pubmed.ncbi.nlm.nih.gov/34644738/
Guillain-Barré syndromeGuillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-vaccineshttps://onlinelibrary.wiley.com/doi/10.1002/ana.26218
Guillain-Barré syndromeGuillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19https://www.sciencedirect.com/science/article/pii/S0736467921006442
Guillain-Barré syndromeGuillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patientshttps://pubmed.ncbi.nlm.nih.gov/34649856/
Guillain-Barré syndromeGuillian Barré syndrome after vaccination with mRNA-127against COVID-19https://pubmed.ncbi.nlm.nih.gov/34477091/
Guillain-Barré syndromeGuillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-mRNA-based vaccinehttps://pubmed.ncbi.nlm.nih.gov/34722067/
Guillain-Barré syndromeMiller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34848426/
Guillain-Barré syndromeNeurological complications of COVID-19https://pubmed.ncbi.nlm.nih.gov/33758714/
Guillain-Barré syndromeRate of recurrent Guillain-Barré syndrome after COVID-19 BNT162bmRNA vaccinehttps://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
Guillain-Barré syndromeSARS-CoV-vaccines are not safe for those with Guillain-Barre syndrome following vaccinationhttps://www.sciencedirect.com/science/article/pii/S2049080121005343
Guillain-Barré syndromeSARS-CoV-vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathyhttps://pubmed.ncbi.nlm.nih.gov/34525410/
Guillain-Barré syndromeSensory Guillain-Barré syndrome after ChAdOxnCov-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S0165572821002186
Guillain-Barré syndromeSensory Guillain-Barré syndrome following ChAdOxnCov-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34416410/
Guillain-Barré syndromeVariant Guillain-Barré syndrome occurring after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34114269/
HaemorrhageAcral hemorrhage after administration of the second dose of SARS-CoV-vaccine. A post-vaccination reactionhttps://pubmed.ncbi.nlm.nih.gov/34092400/742
HaemorrhageLobar hemorrhage with ventricular rupture shortly after the first dose of a SARS CoV-mRNA-based SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34729467/
HaemorrhageLobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA based SARS-CoV-vaccinehttps://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/
HaemorrhageRetinal hemorrhage after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34884407/
Hailey-Hailey diseaseHailey-Hailey disease exacerbation after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34436620/
HeadacheHeadache attributed to COVID-19 (SARS-CoV-coronavirus) vaccination with the ChAdOxnCoV-19 (AZD1222) vaccinehttps://pubmed.ncbi.nlm.nih.gov/34313952/
Hematologic conditionsCollection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-vaccinationhttps://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic
HemolysisCOVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuriahttps://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in
Hemophagocytic lymphohistiocytosisHemophagocytic lymphohistiocytosis after vaccination with ChAdOxnCov-19https://pubmed.ncbi.nlm.nih.gov/34406660/
Hemophagocytic lymphohistiocytosisHemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx nCoV-19)https://pubmed.ncbi.nlm.nih.gov/34862234/
Henoch-Schonlein PurpuraA rare case of Henoch-Schönlein purpura after a of COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34518812/
Henoch-Schonlein PurpuraHenoch-Schönlein purpura following the first dose of COVID-19 viral vector vaccinehttps://pubmed.ncbi.nlm.nih.gov/34696186/
Henoch-Schonlein PurpuraHenoch-Schönlein purpura occurring after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34247902/
Herpes Simplex VirusVaricella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34487581/
HypercoagulabilityCOVID-19 vaccine in patients with hypercoagulability disordershttps://pubmed.ncbi.nlm.nih.gov/34786893/
Immune-Mediated Disease OutbreaksAutoimmune encephalitis after ChAdOx1-S SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34846583/
Immune-Mediated Disease OutbreaksImmune-mediated disease outbreaks or recent-onset disease in 2subjects after mRNA/DNA vaccination against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/33946748/
Immune-Mediated Disease OutbreaksSevere autoimmune hemolytic anemia after receipt of SARS-CoV-mRNA vaccinehttps://onlinelibrary.wiley.com/doi/10.1111/trf.16672
Immune-Mediated Disease OutbreaksSevere autoimmune hemolytic autoimmune anemia after receiving SARS-CoV- mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34549821/
Immune-Mediated Disease OutbreaksImmunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyhttps://www.ncbi.nlm.nih.gov/pubmed/34127481
Immune-Mediated HepatitisAutoimmune hepatitis after COVID vaccinehttps://pubmed.ncbi.nlm.nih.gov/34225251/
Immune-Mediated HepatitisAutoimmune hepatitis developing after ChAdOxnCoV-19 vaccine (Oxford AstraZeneca)https://pubmed.ncbi.nlm.nih.gov/34171435/
Immune-Mediated HepatitisAutoimmune hepatitis developing after coronavirus disease vaccine 2019 (COVID-19)https://pubmed.ncbi.nlm.nih.gov/33862041/
Immune-Mediated HepatitisAutoimmune hepatitis triggered by SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34332438/
Immune-Mediated HepatitisAutoimmune hepatitis triggered by vaccination against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34332438/
Immune-Mediated HepatitisHepatitis C virus reactivation after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34512037/
Immune-Mediated HepatitisImmune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmedhttps://www.sciencedirect.com/science/article/pii/S0168827821020936
Inflammatory MyositisInflammatory myositis after vaccination with ChAdOx1https://pubmed.ncbi.nlm.nih.gov/34585145/
Interstitial lung diseaseVaccine-induced interstitial lung diseasehttps://pubmed.ncbi.nlm.nih.gov/34510014/
Intracerebral HaemorrhageAphasia seven days after the second dose of an mRNA-based SARS-CoV-vaccine. Brain MRI revealed an intracerebral haemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. httpshttps://www.sciencedirect.com/science/article/pii/
Intracerebral HaemorrhageIncidence of acute ischemic stroke after coronavirus vaccination in Indonesiahttps://pubmed.ncbi.nlm.nih.gov/34579636/
Intracerebral HaemorrhageIntracerebral haemorrhage twelve days after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34477089/
Intracerebral HaemorrhageMajor hemorrhagic stroke after ChAdOxnCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34273119/
iTTP episodeFirst report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34105244/
Keratolysis (also termedBilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccinehttps://pubmed.ncbi.nlm.nih.gov/34483273/
Kounis SyndromeKounis syndrome type induced by inactivated SARS-COV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34148772/
Lipschütz ulcers (Vaginal ulcers)Lipschütz ulcers after AstraZeneca COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34366434/
LymphadenopathyA case of cervical lymphadenopathy following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34141500/
LymphadenopathyAcute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021https://pubmed.ncbi.nlm.nih.gov/33706861/
LymphadenopathyAdverse events of COVID injection that may occur in children.Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021https://pubmed.ncbi.nlm.nih.gov/33706861/
LymphadenopathyCervical lymphadenopathy after coronavirus disease vaccination 2019https://pubmed.ncbi.nlm.nih.gov/34526175/
LymphadenopathyCOVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET / CThttps://pubmed.ncbi.nlm.nih.gov/33591026/
LymphadenopathyCOVID-19 post-vaccination lymphadenopathyhttps://pubmed.ncbi.nlm.nih.gov/34432391/
LymphadenopathyCOVID-19 vaccination and lower cervical lymphadenopathy in two-week neck lump clinichttps://pubmed.ncbi.nlm.nih.gov/33947605/
LymphadenopathyCOVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israelhttps://pubmed.ncbi.nlm.nih.gov/34257025/
LymphadenopathyCOVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancieshttps://pubmed.ncbi.nlm.nih.gov/34719892/
LymphadenopathyEvolution of Lymphadenopathy at Pet/MRI after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33625301/
LymphadenopathyEvolution of lymphadenopathy on PET/MRI after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33625301/
LymphadenopathyHypermetabolic lymphadenopathy after administration of BNT162bmRNA vaccine Covid-19https://pubmed.ncbi.nlm.nih.gov/33774684/
LymphadenopathyLymphadenopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33985872/
LymphadenopathyLymphadenopathy associated with COVID-19 vaccination on FDG PET/CT
LymphadenopathyLymphadenopathy associated with the COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33786231/
LymphadenopathyLymphadenopathy in COVID-19 vaccine recipientshttps://pubmed.ncbi.nlm.nih.gov/33625300/
LymphadenopathyMassive cervical lymphadenopathy following vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34601889/
LymphadenopathyOxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG findinghttps://pubmed.ncbi.nlm.nih.gov/33661328/
LymphadenopathyRegional lymphadenopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34731748/
LymphadenopathySupraclavicular lymphadenopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33685772/
LymphadenopathySupraclavicular lymphadenopathy after COVID-19 vaccination in Koreahttps://pubmed.ncbi.nlm.nih.gov/34116295/
LymphadenopathyUnilateral lymphadenopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33713605/
Macroscopic HematuriaA case of outbreak of macroscopic hematuria and IgA nephropathy after SARS CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33932458/
Macroscopic HematuriaHematuria, a generalized petechial rash and headaches after Oxford AstraZeneca ChAdOxnCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34620638/
Metabolic SyndromeChange in blood viscosity after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34868465/
Miller Fisher SyndromeMiller Fisher syndrome after 2019 BNT162bmRNA coronavirus vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34789193/
Miller Fisher SyndromeMiller Fisher syndrome after Pfizer COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34817727/
Multiple sclerosisAcute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximabhttps://pubmed.ncbi.nlm.nih.gov/34015240
Multiple sclerosisHumoral response induced by Prime-Boost vaccination with ChAdOxnCoV-19 and BNT162bmRNA vaccines in a patient with multiple sclerosis treated with teriflunomidehttps://pubmed.ncbi.nlm.nih.gov/34696248/
Multiple sclerosisSevere relapse of multiple sclerosis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34447349/
Multisystem Inflammatory Syndrome (includes termPost-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infectionhttps://pubmed.ncbi.nlm.nih.gov/34852213/
Myocardial InjuryAcute myocardial injury after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34219532/
Myocardial InjuryAcute Myocardial Injury Following COVID-19 Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34219532
MyocarditisAcute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination: Is Kounis Syndrome the Culprit?https://pubmed.ncbi.nlm.nih.gov/34702550/
MyocarditisA case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273https://pubmed.ncbi.nlm.nih.gov/34703815/
MyocarditisA Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13(9), e17890. doihttps://www.ncbi.nlm.nih.gov/pubmed/34660088
MyocarditisA report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologicshttps://pubmed.ncbi.nlm.nih.gov/34601006/
MyocarditisA series of patients with myocarditis after vaccination against SARS-CoV-with mRNA-1279 and BNT162b2https://www.sciencedirect.com/science/article/pii/S1936878X21004861
MyocarditisA series of patients with myocarditis after vaccination against SARS-CoV-with mRNA-79 and BNT162b2https://pubmed.ncbi.nlm.nih.gov/34246585/
MyocarditisA Series of Patients With Myocarditis Following SARS CoV-Vaccination With mRNA-1279 and BNT162b JACC Cardiovasc Imaging, 14(9), 1862-18doihttps://www.ncbi.nlm.nih.gov/pubmed/34246585
MyocarditisAcute myocardial infarction and myocarditis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34586408/
MyocarditisAcute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doihttps://www.ncbi.nlm.nih.gov/pubmed/34586408
MyocarditisAcute myocardial infarction within 2hours after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34292611/
MyocarditisAcute myocarditis after 2019 coronavirus disease vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34734821/
MyocarditisAcute myocarditis after a second dose of COVID-19 mRNA vaccinehttps://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext
MyocarditisAcute myocarditis after administration of BNT162bvaccinehttps://www.sciencedirect.com/science/article/pii/S2214250921001530
MyocarditisAcute myocarditis after administration of the second dose of BNT162bCOVID-19 vaccinehttps://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/
MyocarditisAcute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-infectionhttps://www.sciencedirect.com/science/article/pii/S1930043321005549
MyocarditisAcute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-infectionhttps://pubmed.ncbi.nlm.nih.gov/34367386/
MyocarditisAcute myocarditis after COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0248866321007098
MyocarditisAcute myocarditis after SARS-CoV-mRNA-7mRNA vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34308326/
MyocarditisAcute myocarditis after SARS-CoV-vaccination in a 24-year-old malehttps://pubmed.ncbi.nlm.nih.gov/34334935/
MyocarditisAcute myocarditis after SARS-CoV-vaccination in a 24-year-old manhttps://www.sciencedirect.com/science/article/pii/S0870255121003243
MyocarditisAcute myocarditis after vaccination with COVID-19 mRNA in adults aged 1years or olderhttps://pubmed.ncbi.nlm.nih.gov/34605853/
MyocarditisAcute myocarditis after vaccination with SARS-CoV-mRNA-127mRNAhttps://www.sciencedirect.com/science/article/pii/S2589790X21001931
MyocarditisAcute myocarditis associated with anti-COVID-19 vaccinationhttps://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.
MyocarditisAcute myocarditis associated with COVID-19 vaccinationhttps://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/
MyocarditisAcute myocarditis defined after vaccination with 2019 mRNA of coronavirus diseasehttps://pubmed.ncbi.nlm.nih.gov/34866122/
MyocarditisAcute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-infection. Radiol Case Rep, 16(11), 3321-33doihttps://www.ncbi.nlm.nih.gov/pubmed/34367386
MyocarditisAcute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 1 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doihttps://www.ncbi.nlm.nih.gov/pubmed/34605853
MyocarditisAcute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome), 22(11), 891-89 doihttps://www.ncbi.nlm.nih.gov/pubmed/34709227
MyocarditisAcute myocarditis in a young adult two days after vaccination with Pfizerhttps://pubmed.ncbi.nlm.nih.gov/34709227/
MyocarditisAcute myopericarditis after COVID-19 vaccination in adolescentshttps://pubmed.ncbi.nlm.nih.gov/34589238/
MyocarditisAcute symptomatic myocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34088762/
MyocarditisAcute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccinationhttps://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478
MyocarditisAssociation of myocarditis with COVID-19 messenger RNA BNT162bvaccine COVID-19 in a case series of childrenhttps://pubmed.ncbi.nlm.nih.gov/34374740/
MyocarditisAssociation of myocarditis with COVID-19 messenger RNA vaccine BNT162bin a case series of childrenhttps://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
MyocarditisAssociation of myocarditis with COVID-19 mRNA vaccine in childrenhttps://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-covid-19-vaccine-in-children/
MyocarditisBiopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old manhttps://pubmed.ncbi.nlm.nih.gov/34487236/
MyocarditisBiopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old malehttps://www.ncbi.nlm.nih.gov/pubmed/34487236
MyocarditisBiventricular systolic dysfunction in acute myocarditis after SARS-CoV- mRNA-7vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34601566/
MyocarditisCardiac imaging of acute myocarditis after vaccination with COVID-19 mRNAhttps://pubmed.ncbi.nlm.nih.gov/34402228/
MyocarditisCardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), e2doihttps://www.ncbi.nlm.nih.gov/pubmed/34402228
MyocarditisCardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doihttps://www.ncbi.nlm.nih.gov/pubmed/34704459
MyocarditisCardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34496880
MyocarditisCardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccinationhttps://jcmronline.biomedcentral.com/articles/10.1186/s12968-021-00795-4
MyocarditisOccurrence of acute infarct-like myocarditis following COVID-19 vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34333695
MyocarditisEpidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34849657
MyocarditisClinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNAhttps://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis
MyocarditisClinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adultshttps://pubmed.ncbi.nlm.nih.gov/34865500/
MyocarditisClinically Suspected Myocarditis Temporally Related to COVID- Vaccination in Adolescents and Young Adults. Circulation. doihttps://www.ncbi.nlm.nih.gov/pubmed/34865500
MyocarditisCOVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-5doihttps://www.ncbi.nlm.nih.gov/pubmed/34564344
MyocarditisCOVID 19 vaccine for adolescents. Concern for myocarditis and pericarditishttps://www.mdpi.com/2036-7503/13/3/61.
MyocarditisCOVID-19 mRNA vaccination and myocarditishttps://pubmed.ncbi.nlm.nih.gov/34268277/
MyocarditisCOVID-19 Vaccination Associated with Myocarditis in Adolescentshttps://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf
MyocarditisCOVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, 148(5). doihttps://www.ncbi.nlm.nih.gov/pubmed/34389692
MyocarditisCOVID-19 vaccine and myocarditishttps://pubmed.ncbi.nlm.nih.gov/34399967/
MyocarditisCOVID-19 vaccine-induced myocarditishttps://www.sciencedirect.com/science/article/pii/S1871402121002253
MyocarditisCOVID-19 vaccines and myocarditishttps://pubmed.ncbi.nlm.nih.gov/34246566/
MyocarditisEosinophilic Myocarditis Following Coronavirus Disease 20 (COVID-) Vaccination. Circ J. doihttps://www.ncbi.nlm.nih.gov/pubmed/34955479
MyocarditisEpidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean childrenhttps://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-1360706.
MyocarditisEpidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Childrenhttps://www.ncbi.nlm.nih.gov/pubmed/34402230
MyocarditisEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co vaccinationhttps://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179
MyocarditisEpidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canadahttps://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1
MyocarditisFeatures of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doihttps://www.ncbi.nlm.nih.gov/pubmed/34860360
MyocarditisGa-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34746968/
MyocarditisIn-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccinehttps://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038
MyocarditisLymphohistocytic myocarditis after vaccination with COVID-19 Ad2COVS viral vectorhttps://www.sciencedirect.com/science/article/pii/S2352906721001573
MyocarditisLymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad2COVShttps://pubmed.ncbi.nlm.nih.gov/34514078/
MyocarditismRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-3doihttps://www.ncbi.nlm.nih.gov/pubmed/34393110
MyocarditisMultimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-73https://pubmed.ncbi.nlm.nih.gov/34848416/
MyocarditisMyocarditis / pericarditis associated with COVID-19 vaccinehttps://science.gc.ca/eic/site/063.nsf/eng/h_98291.html
MyocarditisMyocarditis after 2019 coronavirus disease mRNA vaccinehttps://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408
MyocarditisMyocarditis after BNT162bmRNA Vaccine against Covid-19 in Israel. N Engl J Med, 385(23), 2140-21doihttps://www.ncbi.nlm.nih.gov/pubmed/34614328
MyocarditisMyocarditis after BNT162bvaccination in a healthy malehttps://pubmed.ncbi.nlm.nih.gov/34229940/
MyocarditisMyocarditis after BNT162bvaccination in a healthy male. Am J Emerg Med, 50, 81e811-81edoihttps://www.ncbi.nlm.nih.gov/pubmed/34229940
MyocarditisMyocarditis after COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/34546329/
MyocarditisMyocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med, 385(23), 2132-21doihttps://www.ncbi.nlm.nih.gov/pubmed/34614329
MyocarditisMyocarditis after Covid-19 vaccination in a large healthcare organizationhttps://www.nejm.org/doi/10.1056/NEJMoa2110737
MyocarditisMyocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. militaryhttps://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C
MyocarditisMyocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “2male patients, including 2previously healthy military members, myocarditis was identified within days after receipt of the vaccine”https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
MyocarditisMyocarditis after mRNA vaccination against SARS-CoV-2, a case serieshttps://www.sciencedirect.com/science/article/pii/S2666602221000409
MyocarditisMyocarditis after SARS-CoV-mRNA vaccination, a case serieshttps://pubmed.ncbi.nlm.nih.gov/34396358/
MyocarditisMyocarditis after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34118375/
MyocarditisMyocarditis after vaccination against covid-BMJ, 375, n3090. doihttps://www.ncbi.nlm.nih.gov/pubmed/34916217
MyocarditisMyocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines httpshttps://www.cureus.com/articles/61030-myocarditis-and-othercardiovascular-complications-of-the-mrna-based-covid-19-vaccines
MyocarditisMyocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34277198/
MyocarditisMyocarditis and Other Cardiovascular Complications of the mRNA Based COVID- Vaccines. Cureus, 13(6), e155doihttps://www.ncbi.nlm.nih.gov/pubmed/34277198
MyocarditisMyocarditis and Pericarditis After COVID-19 mRNA Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34375696
MyocarditisMyocarditis and pericarditis after COVID-19 vaccinationhttps://jamanetwork.com/journals/jama/fullarticle/2782900
MyocarditisMyocarditis and pericarditis after vaccination with COVID-19 mRNAhttps://www.sciencedirect.com/science/article/pii/S0828282X21006243
MyocarditisMyocarditis and Pericarditis following COVID-19 Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34834458
MyocarditisMyocarditis and Pericarditis Following mRNA COVID-19 Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34356586
MyocarditisMyocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccineshttps://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/6442104
MyocarditisMyocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doihttps://www.ncbi.nlm.nih.gov/pubmed/34849667
MyocarditisMyocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/34849667/
MyocarditisMyocarditis and pericarditis in association with COVID-19 mRNA vaccinationhttps://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/
MyocarditisMyocarditis and pericarditis in association with COVID-19 mRNA-vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34805376
MyocarditisMyocarditis associated with COVID-19 mRNA vaccinationhttps://pubs.rsna.org/doi/10.1148/radiol.2021211430
MyocarditisMyocarditis associated with COVID-19 vaccinationhttps://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236
MyocarditisMyocarditis associated with COVID-19 vaccination in adolescentshttps://publications.aap.org/pediatrics/article/148/5/e2021053427/181357
MyocarditisMyocarditis Associated with mRNA COVID- Vaccination. Radiology, 301(2), E409-E4doihttps://www.ncbi.nlm.nih.gov/pubmed/34282971
MyocarditisMyocarditis associated with SARS-CoV-mRNA vaccination in children aged 1to 1yearshttps://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
MyocarditisMyocarditis associated with vaccination with COVID-19 mRNAhttps://pubs.rsna.org/doi/10.1148/radiol.2021211430
MyocarditisMyocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescentshttps://pubmed.ncbi.nlm.nih.gov/34704459/
MyocarditisMyocarditis Following a COVID-19 Messenger RNA Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34840235
MyocarditisMyocarditis following BNT162bmRNA Covid-19 mRNA vaccine in Israelhttps://pubmed.ncbi.nlm.nih.gov/34614328/
MyocarditisMyocarditis Following COVID-19 mRNA Vaccinehttps://www.ncbi.nlm.nih.gov/pubmed/34734240
MyocarditisMyocarditis following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34739045/
MyocarditisMyocarditis following COVID-19 vaccination – A case series. Vaccine, 39(42), 6195-6200. doihttps://www.ncbi.nlm.nih.gov/pubmed/34535317
MyocarditisMyocarditis following COVID-19 vaccination. Int J Cardiol Heart Vasc, 36, 1008doihttps://www.ncbi.nlm.nih.gov/pubmed/34568540
MyocarditisMyocarditis following COVID-19 vaccination. Radiol Case Rep, 16(8), 22-21doihttps://www.ncbi.nlm.nih.gov/pubmed/34025885
MyocarditisMyocarditis following immunization with Covid-19 mRNAhttps://www.nejm.org/doi/full/10.1056/NEJMc2109975
MyocarditisMyocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Militaryhttps://pubmed.ncbi.nlm.nih.gov/34185045/
MyocarditisMyocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-120 doihttps://www.ncbi.nlm.nih.gov/pubmed/34185045
MyocarditisMyocarditis Following mRNA COVID- Vaccine. Pediatr Emerg Care, 37(11), 583-5doihttps://www.ncbi.nlm.nih.gov/pubmed/34731877
MyocarditisMyocarditis Following mRNA COVID-19 Vaccinehttps://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_mRNA_COVID_19_Vaccine.9.aspx
MyocarditisMyocarditis following mRNA vaccination against SARS CoV-2, a case series. Am Heart J Plus, 8, 1000doihttps://www.ncbi.nlm.nih.gov/pubmed/34396358
MyocarditisMyocarditis following vaccination with BNT162bin a healthy malehttps://www.sciencedirect.com/science/article/pii/S0735675721005362
MyocarditisMyocarditis following vaccination with Covid-19 in a large healthcare organizationhttps://pubmed.ncbi.nlm.nih.gov/34614329/
MyocarditisMyocarditis following vaccination with COVID-19 messenger RNAhttps://pubmed.ncbi.nlm.nih.gov/34840235/
MyocarditisMyocarditis in the setting of a recent COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34712497/
MyocarditisMyocarditis occurring after immunization with COVID-19 mRNA-based COVID-19 vaccineshttps://jamanetwork.com/journals/jamacardiology/fullarticle/2781600
MyocarditisMyocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM. doihttps://www.ncbi.nlm.nih.gov/pubmed/34463755
MyocarditisMyocarditis temporally associated with COVID-19 vaccinationhttps://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.
MyocarditisMyocarditis with COVID-19 mRNA vaccineshttps://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135
MyocarditisMyocarditis With COVID-19 mRNA Vaccines. Circulation, 4(6), 471-4doihttps://www.ncbi.nlm.nih.gov/pubmed/34281357
MyocarditisMyocarditis, pericarditis and cardiomyopathy after COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S1443950621011562
MyocarditisMyocarditis, pericarditis, and cardiomyopathy after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34340927/
MyocarditisMyocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccinationhttps://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext
MyocarditisOccurrence of acute infarct-like myocarditis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34333695/
MyocarditisOccurrence of acute infarct-like myocarditis after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34333695/
MyocarditisPatients with acute myocarditis after COVID-19 mRNA vaccinationhttps://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
MyocarditisPatients with acute myocarditis after vaccination withCOVID-19 mRNAhttps://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
MyocarditisPatients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1 doihttps://www.ncbi.nlm.nih.gov/pubmed/34185046
MyocarditisPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccinationhttps://academic.oup.com/jpids/article/10/10/962/6329543.
MyocarditisPossible Association Between COVID-19 Vaccine and Myocarditishttps://pubmed.ncbi.nlm.nih.gov/34246586/
MyocarditisPotential association between COVID-19 vaccine and myocarditishttps://www.sciencedirect.com/science/article/pii/S1936878X2100485X
MyocarditisPremature myocardial infarction or side effect of COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33824804/
MyocarditisRecurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescenthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/
MyocarditisRecurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent malehttps://pubmed.ncbi.nlm.nih.gov/34166671/
MyocarditisReply to “Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination”https://www.ncbi.nlm.nih.gov/pubmed/34463770
MyocarditisRisk of Myocarditis from COVID- Infection in People Under Age 20https://www.ncbi.nlm.nih.gov/pubmed/34341797
MyocarditisRisks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-infection. Nat Med. doihttps://www.ncbi.nlm.nih.gov/pubmed/34907393
MyocarditisSelf-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162bmRNA vaccine. Cardiol Young, 1- doihttps://www.ncbi.nlm.nih.gov/pubmed/34180390
MyocarditisSelf-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162bmRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34180390/
MyocarditisSevere myocarditis associated with COVID-19 vaccinehttps://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext
MyocarditisShedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipientshttps://pubmed.ncbi.nlm.nih.gov/34696294/
MyocarditisShould Tmapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doihttps://www.ncbi.nlm.nih.gov/pubmed/34933012
MyocarditisSTEMI mimicryhttps://pubmed.ncbi.nlm.nih.gov/34756746/
MyocarditisSymptomatic Acute Myocarditis in Adolescents after Pfizer-BioNTech COVID-19 Vaccinationhttps://pediatrics.aappublications.org/content/148/3/e2021052478
MyocarditisTemporal association between COVID-19 vaccine Ad2COVS and acute myocarditishttps://www.sciencedirect.com/science/article/pii/S1553838921005789
MyocarditisTemporal association between the COVID- Ad2COVS vaccine and acute myocarditishttps://www.ncbi.nlm.nih.gov/pubmed/34420869
MyocarditisThe new COVID-19 mRNA vaccine platform and myocarditishttps://pubmed.ncbi.nlm.nih.gov/34312010/
MyocarditisTmapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process. QJM. doihttps://www.ncbi.nlm.nih.gov/pubmed/34931681
MyocarditisUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipientshttps://www.ncbi.nlm.nih.gov/pubmed/34237049
MyocarditisYoung male with myocarditis after mRNA-7coronavirus disease-2019 (COVID-19) mRNA vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34744118/
MyocarditisYoung Male With Myocarditis Following mRNA-127Vaccination Against Coronavirus Disease-19 (COVID-19). Circ J. doihttps://www.ncbi.nlm.nih.gov/pubmed/34744118
MyocarditisMyocarditis following COVID-19 mRNA vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34092429
MyocarditisMyocarditis following COVID-19 mRNA vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34342500
MyopericarditisAcute myocarditis after administration of BNT162bvaccine against COVID-19https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X
MyopericarditisAcute myopericarditis after COVID-19 vaccine in adolescentshttps://pubmed.ncbi.nlm.nih.gov/34589238/
MyopericarditisCOVID-19 mRNA vaccination and development of CMR-confirmed myopericarditishttps://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09
MyopericarditisImportant information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescentshttps://www.sciencedirect.com/science/article/pii/S0022347621007496
MyopericarditisImportant Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, doihttps://www.ncbi.nlm.nih.gov/pubmed/34332972
MyopericarditisInfluenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBasehttps://www.ncbi.nlm.nih.gov/pubmed/33406694
MyopericarditisInsights from a murine model of COVID-19 mRNA vaccine-induced myopericarditishttps://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059
MyopericarditisInsights from a murine model of myopericarditis induced by COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34453510/
MyopericarditisIntravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse modelhttps://t.co/j0IEM8cMXI
MyopericarditismRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescentshttps://www.ncbi.nlm.nih.gov/pubmed/34952008
MyopericarditisMyopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 1to 1Years of Age. J Pediatr, 238, 26-3edoihttps://www.ncbi.nlm.nih.gov/pubmed/34339728
MyopericarditisMyopericarditis after Pfizer messenger ribonucleic acid coronavirus coronavirus disease vaccine in adolescentshttps://pubmed.ncbi.nlm.nih.gov/34228985/
MyopericarditisMyopericarditis after Pfizer mRNA COVID-19 vaccination in adolescentshttps://www.sciencedirect.com/science/article/pii/S002234762100665X
MyopericarditisMyopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-3 doihttps://www.ncbi.nlm.nih.gov/pubmed/34228985
MyopericarditisMyopericarditis after vaccination with COVID-19 mRNA in adolescents 1to 1years of agehttps://www.sciencedirect.com/science/article/pii/S0022347621007368
MyopericarditisMyopericarditis in a previously healthy adolescent male after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34133825/
MyopericarditisMyopericarditis in a previously healthy adolescent male following COVID-19 vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34133825
MyopericarditisPopulation-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e doihttps://www.ncbi.nlm.nih.gov/pubmed/34889875
MyopericarditisReport of a case of myopericarditis after vaccination with BNT162bCOVID-19 mRNA in a young Korean malehttps://pubmed.ncbi.nlm.nih.gov/34636504/
MyopericarditisRecurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescenthttps://www.ncbi.nlm.nih.gov/pubmed/34904134
Nephrotic SyndromeNephrotic syndrome after ChAdOxnCoV-19 vaccine against SARScoV-2https://pubmed.ncbi.nlm.nih.gov/34250318/
Nephrotic SyndromeNew-onset nephrotic syndrome after Janssen COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34342187/
Nerve And Muscle Adverse EventsNerve and muscle adverse events after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34452064/
Neuroimaging Findings in Post COVID-19 VaccinationSpectrum of neuroimaging findings in post-CoVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34842783/
Neurologic PhantosmiaUnique imaging findings of neurologic phantosmia after Pfizer-BioNtech COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34096896/
Neurological Autoimmune DiseasesNeurological autoimmune diseases after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34668274/
Neurological SymptomsNeurological complications after the first dose of COVID-19 vaccines and SARS CoV-infectionhttps://pubmed.ncbi.nlm.nih.gov/34697502/
Neurological SymptomsNeurological side effects of SARS-CoV-vaccineshttps://pubmed.ncbi.nlm.nih.gov/34750810/
Neurological SymptomsNeurological symptoms and neuroimaging alterations related to COVID-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S0899707121003557.
Neurological Symptomsn-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccineshttps://pubmed.ncbi.nlm.nih.gov/34688190/
Neurological SymptomsSpectrum of neurological complications after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34719776/
Neuromyelitis OpticaBeware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19https://pubmed.ncbi.nlm.nih.gov/34189662/
Neuromyelitis OpticaNeuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus mRNA-1273https://pubmed.ncbi.nlm.nih.gov/34660149/
Ocular Adverse EventsOcular adverse events following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34559576/
Oculomotor ParalysisTransient oculomotor paralysis after administration of RNA-127messenger vaccine for SARS-CoV-diplopia after COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34369471/
OrofacialReported orofacial adverse effects from COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/33527524/
Pancreas Allograft RejectionPancreas allograft rejection after ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34781027/
Parsonage-Turner SyndromeParsonage-Turner syndrome associated with SARS-CoV-or SARS-CoV- vaccination. Comment onhttps://pubmed.ncbi.nlm.nih.gov/34139321/
Pathophysiologic AlterationsExtensive investigations revealed consistent pathophysiologic alterations after vaccination with COVID-19 vaccineshttps://www.nature.com/articles/s41421-021-00329-3
PericarditisA case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United Stateshttps://pubmed.ncbi.nlm.nih.gov/34635376/
PericarditisAcute myocarditis after the second dose of SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34236331/
PericarditisAcute pericarditis and cardiac tamponade after vaccination with Covid-19https://pubmed.ncbi.nlm.nih.gov/34749492/
PericarditisPericarditis after administration of BNT162bmRNA COVID-19 mRNA vaccinehttps://www.sciencedirect.com/science/article/pii/S1885585721002218
PericarditisPericarditis after administration of COVID-19 mRNA BNT162bvaccinehttps://pubmed.ncbi.nlm.nih.gov/34364831/
PericarditisPericarditis after administration of the BNT162bmRNA vaccine COVID-19https://pubmed.ncbi.nlm.nih.gov/34149145/
PericarditisUnusual presentation of acute pericarditis after vaccination against SARS-COV- mRNA-123Modernhttps://pubmed.ncbi.nlm.nih.gov/34447639/
PerimyocarditisAcute perimyocarditis after the first dose of COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34515024/
PerimyocarditisPerimyocarditis after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34866957/
PerimyocarditisPerimyocarditis following first dose of the mRNA-127SARS-CoV- (Moderna) vaccine in a healthy young malehttps://www.ncbi.nlm.nih.gov/pubmed/34348657
PerimyocarditisPerimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccinehttps://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543
PerimyocarditisUnusual Presentation of Acute Perimyocarditis Following SARS-COV-mRNA-123Moderna Vaccination. Cureus, 13(7), e16590. doihttps://www.ncbi.nlm.nih.gov/pubmed/34447639
PerimyocarditisWeighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-9doihttps://www.ncbi.nlm.nih.gov/pubmed/34270752
Petechiae (also includesPetechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34513435/
PolyarthralgiaPolyarthralgia and myalgia syndrome after vaccination with ChAdOxnCOV-19https://pubmed.ncbi.nlm.nih.gov/34463066/
Post-MortemA look at the role of postmortem immunohistochemistry in understanding the inflammatory pathophysiology of COVID-19 disease and vaccine-related thrombotic adverse eventshttps://pubmed.ncbi.nlm.nih.gov/34769454/
Post-MortemCOVID-19 vaccine and deathhttps://pubmed.ncbi.nlm.nih.gov/34073536/
Post-MortemPost-mortem investigation of deaths after vaccination with COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34591186/
Post-MortemAutopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Reviewhttps://www.ncbi.nlm.nih.gov/pubmed/34945172
Pregnant WomanPreliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Personshttps://www.nejm.org/doi/full/10.1056/NEJMoa2104983
Prion DiseaseCOVID-19 RNA-based vaccines and the risk of prion diseasehttps://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-disease-1503.pdf
Process-Related ImpuritiesProcess-related impurities in the ChAdOxnCov-19 vaccinehttps://www.researchsquare.com/article/rs-477964/v1
PsoriasisExacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b vaccineshttps://pubmed.ncbi.nlm.nih.gov/34427024/
PsoriasisOnset / outbreak of psoriasis after Corona virus ChAdOxnCoV-19 vaccine (Oxford AstraZeneca / Covishield)https://pubmed.ncbi.nlm.nih.gov/34350668/
Pulmonary EmbolismA case of acute pulmonary embolism after immunization with SARS-CoV-mRNAhttps://pubmed.ncbi.nlm.nih.gov/34452028/
Pulmonary EmbolismIsolated pulmonary embolism after COVID vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34804412/
Pulmonary EmbolismMyocardial infarction, stroke, and pulmonary embolism after BNT162bmRNA COVID-19 vaccine in persons aged 7years or olderhttps://pubmed.ncbi.nlm.nih.gov/34807248/
Purpura Annularis TelangiectodesGeneralized purpura annularis telangiectodes after SARS-CoV-mRNA vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34236717/
Refractory Status EpilepticusNew-onset refractory status epilepticus after chadoxncov-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/s0165572821001569
RhabdomyolysisCase Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34659268/
RhabdomyolysisCOVID-19 vaccine-induced rhabdomyolysishttps://pubmed.ncbi.nlm.nih.gov/34186348/
RhabdomyolysisRhabdomyolysis and fasciitis induced by COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34435250/
RhabdomyolysisRhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34435250/
Safety in AdolescentsCOVID-19 Vaccine Safety in Adolescents Aged 12-1Years – United States, December 14, 2020-July 16, 20MMWR Morb Mortal Wkly Rep, 70(31), 1053-10doihttps://www.ncbi.nlm.nih.gov/pubmed/34351881
Safety in AdolescentsSafety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doihttps://www.ncbi.nlm.nih.gov/pubmed/34492161
Safety Monitoring of the Janssen VaccineSafety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine – United States, March-April 20MMWR Morb Mortal Wkly Rep, 70(18), 680-6 doihttps://www.ncbi.nlm.nih.gov/pubmed/33956784
Sensorineural Hearing LossSudden sensorineural hearing loss after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34670143/
Serious Adverse Events Among Health Care ProfessionalsPrevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOxnCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021https://pubmed.ncbi.nlm.nih.gov/34819146/
Shingles (includes termShingles-like skin lesion after vaccination with AstraZeneca for COVID-19https://pubmed.ncbi.nlm.nih.gov/34631069/
Skin ReactionsA case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda Universityhttps://pubmed.ncbi.nlm.nih.gov/34423106/
Skin ReactionsSkin reactions after vaccination against SARS-COV-2https://pubmed.ncbi.nlm.nih.gov/34254291/
Skin ReactionsSkin reactions reported after Moderna and Pfizer’s COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33838206/
Squamous Cell CarcinomaSquamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)https://pubmed.ncbi.nlm.nih.gov/34612003/
Still’s DiseaseAn outbreak of Still’s disease after COVID-19 vaccination in a 34-year-old patienthttps://pubmed.ncbi.nlm.nih.gov/34797392/
Sweet’s SyndromeSweet’s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly womanhttps://pubmed.ncbi.nlm.nih.gov/34590397/
Systemic Lupus ErythematosusEffective DNA damage response after acute but not chronic immune challengehttps://www.ncbi.nlm.nih.gov/pubmed/34089859
Systemic Lupus ErythematosusInduction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34291477/
Takotsubo cardiomyopathyTakotsubo (stress) cardiomyopathy after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34625447/
Takotsubo cardiomyopathyTakotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysishttps://pubmed.ncbi.nlm.nih.gov/34731486/
Takotsubo cardiomyopathyTakotsubo cardiomyopathy after vaccination with mRNA COVID-19https://www.sciencedirect.com/science/article/pii/S1443950621011331
Takotsubo cardiomyopathyTakotsubo syndrome after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34539938/
ThrombocytopeniaA case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOxnCoV-19 against SARS-CoV-2https://pubmed.ncbi.nlm.nih.gov/34137813/
ThrombocytopeniaA case of vaccine-induced immune-immune thrombotic thrombocytopenia with massive arteriovenous thrombosishttps://pubmed.ncbi.nlm.nih.gov/34059191/
ThrombocytopeniaA prothrombotic thrombocytopenic disorder resembling heparin-induced thrombocytopenia after coronavirus-19 vaccinationhttps://europepmc.org/article/PPR/PPR304469435.
ThrombocytopeniaA rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospitalhttps://pubmed.ncbi.nlm.nih.gov/34535492/
ThrombocytopeniaAbdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34546343/
ThrombocytopeniaAcquired thrombotic thrombocytopenic thrombocytopenic purpurahttps://pubmed.ncbi.nlm.nih.gov/34105247/
ThrombocytopeniaAdenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndromehttps://pubmed.ncbi.nlm.nih.gov/34407607/
ThrombocytopeniaAn observational study to identify the prevalence of thrombocytopenia and anti-PF/ polyanion antibodies in Norwegian health care workers after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33909350/
ThrombocytopeniaAustralian and New Zealand approach to the diagnosis and treatment of vaccine induced immune thrombosis and immune thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34490632/
ThrombocytopeniaBilateral thalamic strokehttps://pubmed.ncbi.nlm.nih.gov/34820232/
ThrombocytopeniaA Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34751013/
ThrombocytopeniaCerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford AstraZeneca COVID-19https://pubmed.ncbi.nlm.nih.gov/34033927/
ThrombocytopeniaCerebral venous vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34373413/
ThrombocytopeniaChAdOx1 interacts with CAR and PFwith implications for thrombosis with thrombocytopenia syndromehttps://www.science.org/doi/10.1126/sciadv.abl8213
ThrombocytopeniaChAdOx1 nCoV-19 vaccine-associated thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34483267/
ThrombocytopeniaComplicated of long-term vaccine-induced thrombotic immune thrombocytopenia Ahttps://pubmed.ncbi.nlm.nih.gov/34835275/
ThrombocytopeniaCOVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosityhttps://pubmed.ncbi.nlm.nih.gov/34509271/
ThrombocytopeniaCOVID-19 vaccine-induced thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34527501/
ThrombocytopeniaEarly results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad2COVShttps://www.sciencedirect.com/science/article/pii/S0196064421003425
ThrombocytopeniaExacerbation of immune thrombocytopenia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34075578/
ThrombocytopeniaFatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulinshttps://pubmed.ncbi.nlm.nih.gov/34382387/
ThrombocytopeniaImages of immune thrombotic thrombocytopenia induced by Oxford / AstraZeneca® COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33962903/
ThrombocytopeniaImmune complexes, innate immunity and NETosis in ChAdOxvaccine-induced thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34405870/
ThrombocytopeniaImmune thrombocytopenia after immunization with Vaxzevria ChadOx1-S vaccine (AstraZeneca), Victoria, Australiahttps://pubmed.ncbi.nlm.nih.gov/34756770/
ThrombocytopeniaImmune thrombocytopenia after vaccination during the COVID-19 pandemichttps://pubmed.ncbi.nlm.nih.gov/34435486/
ThrombocytopeniaImmune thrombocytopenia in a 22-year-old post Covid-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33476455/
ThrombocytopeniaImmune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOxnCov-19)https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.
ThrombocytopeniaImmune-mediated thrombocytopenia associated with Ad2COVS vaccine (Janssen; Johnson & Johnson)https://pubmed.ncbi.nlm.nih.gov/34469919/
ThrombocytopeniaImmune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly womanhttps://pubmed.ncbi.nlm.nih.gov/34513446/
ThrombocytopeniaIntracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34646685/
ThrombocytopeniaLethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 2COVShttps://pubmed.ncbi.nlm.nih.gov/34626338/
ThrombocytopeniaLimb ischemia and pulmonary artery thrombosis after ChAdOxnCoV-19 vaccine (Oxford-AstraZeneca)https://pubmed.ncbi.nlm.nih.gov/33990339/
ThrombocytopeniaNeurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-vaccination in vaccine-induced thrombotic thrombocytopenia-VITThttps://pubmed.ncbi.nlm.nih.gov/34202817/
ThrombocytopeniaNewly diagnosed immune thrombocytopenia in a pregnant patient after coronavirus disease 2019 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34420249/
ThrombocytopeniaPeduncular, symptomatic cavernous bleeding after immune thrombocytopenia induced SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34549178/
ThrombocytopeniaPortal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34598301/
ThrombocytopeniaProcoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34011137/
ThrombocytopeniaPulmonary embolism, transient ischemic attack, and thrombocytopenia after Johnson & Johnson COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34261635/
ThrombocytopeniaPurpuric rash and thrombocytopenia after mRNA-127(Modern) COVID-19 vaccinehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
ThrombocytopeniaRelapse of immune thrombocytopenia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34591991/
ThrombocytopeniaRelapse of immune thrombocytopenia after covid-19 vaccination in young male patienthttps://pubmed.ncbi.nlm.nih.gov/34804803/
ThrombocytopeniaRenal vein thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic immune thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/34268278/
ThrombocytopeniaRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-positive testinghttps://www.ncbi.nlm.nih.gov/pubmed/34446426
ThrombocytopeniaSecondary immune thrombocytopenia (ITP) associated with ChAdOxCovid-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34377889/
ThrombocytopeniaSevere and refractory immune thrombocytopenia occurring after SARS-CoV- vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33854395/
ThrombocytopeniaSevere immune thrombocytopenia following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34653943/
ThrombocytopeniaSevere, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-Vaccine. J Blood Med, 12, 221-2doihttps://www.ncbi.nlm.nih.gov/pubmed/33854395
ThrombocytopeniaSpontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34144250/
ThrombocytopeniaSuccessful treatment of vaccine-induced immune thrombotic thrombocytopenia in a 26-year-old female patienthttps://pubmed.ncbi.nlm.nih.gov/34614491/
ThrombocytopeniaThrombocytopenia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34332437/
ThrombocytopeniaThrombocytopenia following Pfizer and Moderna SARS CoV-vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/33606296
ThrombocytopeniaThrombocytopenia following Pfizer and Moderna SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33606296/
ThrombocytopeniaThrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34331506/
ThrombocytopeniaThrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-33doihttps://www.ncbi.nlm.nih.gov/pubmed/34006408
ThrombocytopeniaThrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33877737/
ThrombocytopeniaThrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)https://pubmed.ncbi.nlm.nih.gov/34006408/
ThrombocytopeniaThrombosis and SARS-CoV-vaccineshttps://pubmed.ncbi.nlm.nih.gov/34237213/
ThrombocytopeniaThrombotic thrombocytopenia after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34071883/
ThrombocytopeniaTransient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad2COVShttps://pubmed.ncbi.nlm.nih.gov/34516272/
ThrombocytopeniaTreatment of acute ischemic stroke associated with ChAdOxnCoV-19 vaccine induced immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34461442/
ThrombocytopeniaVaccine-induced immune thrombotic thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/34159588/
ThrombocytopeniaVaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic reviewhttps://www.sciencedirect.com/science/article/pii/S0022510X21003014
ThrombocytopeniaVaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOxnCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34171649/
ThrombocytopeniaVaccine-induced thrombocytopenia with severe headachehttps://pubmed.ncbi.nlm.nih.gov/34525282/
ThrombocytopeniaVaccine-induced thrombotic thrombocytopenia after Ad2COVS vaccination in a man presenting as acute venous thromboembolismhttps://pubmed.ncbi.nlm.nih.gov/34096082/
ThrombocytopeniaVenous thromboembolism and mild thrombocytopenia after ChAdOxnCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34384129/
ThrombocytopeniaVenous thromboembolism and mild thrombocytopenia after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34384129/
ThrombocytopeniaVITT (vaccine-induced immune thrombotic thrombocytopenia) after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34731555/
ThrombophiliaAntiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccinationhttps://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ
ThrombophlebitisIdiopathic external jugular vein thrombophlebitis after coronavirus disease vaccination (COVID-19)https://pubmed.ncbi.nlm.nih.gov/33624509/
Thrombosis0.Case study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34781321/
Thrombosis59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism days after a first dose of Pfizer-BioNTech BNT162bmRNA vaccine COVID-19https://pubmed.ncbi.nlm.nih.gov/34117206/
ThrombosisA case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162bvaccine (Pfizer-Biontech)https://pubmed.ncbi.nlm.nih.gov/34820240/
ThrombosisA case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosishttps://pubmed.ncbi.nlm.nih.gov/34843991/
ThrombosisAcute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOxnCov-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34175640/
ThrombosisAcute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/34580132/
ThrombosisAcute thrombosis of the coronary tree after vaccination against COVID-19https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988
ThrombosisAge- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad2COVS COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34724036/
ThrombosisAn unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34790811/
ThrombosisAnaphylactoid reaction and coronary thrombosis related to COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34863404/
ThrombosisAntibody epitopes in vaccine-induced immune immune thrombotic thrombocytopeniahttps://www.nature.com/articles/s41586-021-03744-4
ThrombosisArterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norwayhttps://pubmed.ncbi.nlm.nih.gov/33952445/
ThrombosisAtypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca)https://pubmed.ncbi.nlm.nih.gov/34083026/
ThrombosisAutoimmune roots of thrombotic events after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34508917/
ThrombosisAutoimmunity roots of thrombotic events after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34508917/
ThrombosisBilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/33864750/
ThrombosisCAd2COV2-S vaccination may reveal hereditary thrombophiliahttps://pubmed.ncbi.nlm.nih.gov/34632750/
ThrombosisCarotid artery immune thrombosis induced by adenovirus-vectored COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34312301/
ThrombosisCase report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34609603/
ThrombosisCase series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospitalhttps://pubmed.ncbi.nlm.nih.gov/34694650/
Thrombosisceliac artery and splenic artery thrombosis complicated by splenic infarction days after the first dose of Oxford vaccine, causal relationship or coincidencehttps://pubmed.ncbi.nlm.nih.gov/34261633/
ThrombosisCerebral venous sinus thrombosis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34327553/
ThrombosisCerebral venous sinus thrombosis after mRNA-based COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34783932/
ThrombosisCerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2https://pubmed.ncbi.nlm.nih.gov/34796065/
ThrombosisCerebral venous sinus thrombosis following vaccination with ChAdOx1https://pubmed.ncbi.nlm.nih.gov/34706921/
ThrombosisCerebral venous sinus thrombosis following vaccination with Pfizer-BioNTech COVID-19 (BNT162b2)https://pubmed.ncbi.nlm.nih.gov/34595867/
ThrombosisCerebral venous sinus thrombosis negative for anti-PFantibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulationhttps://pubmed.ncbi.nlm.nih.gov/34186376/
ThrombosisCerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese manhttps://pubmed.ncbi.nlm.nih.gov/34630307/
ThrombosisCharacteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-vaccinehttps://jamanetwork.com/journals/jamaneurology/fullarticle/2784622
ThrombosisClinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOxnCov-19; httpshttps://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.
ThrombosisClinical features of vaccine-induced thrombocytopenia and immune thrombosishttps://pubmed.ncbi.nlm.nih.gov/34379914/
ThrombosisComments on thrombosis after vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34788138
ThrombosisComparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance databasehttps://pubmed.ncbi.nlm.nih.gov/34375510/
ThrombosisComparison of vaccine-induced thrombotic episodes between ChAdOxnCoV-19 and Ad2COV.S vaccineshttps://www.sciencedirect.com/science/article/abs/pii/S0896841121000895
ThrombosisComparison of vaccine-induced thrombotic events between ChAdOxnCoV-19 and Ad2COV.S vaccineshttps://pubmed.ncbi.nlm.nih.gov/34139631/
ThrombosisConcerns for adverse effects of thrombocytopenia and thrombosis after adenovirus vectored COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34541935/
ThrombosisCoronavirus (COVID-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/34033367/
ThrombosisCOVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS)https://pubmed.ncbi.nlm.nih.gov/34698582/
ThrombosisCOVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formationhttps://pubmed.ncbi.nlm.nih.gov/34624910/
ThrombosisCOVID-19 vaccine-induced immune-immune thrombotic thrombocytopeniahttps://www.sciencedirect.com/science/article/pii/S1665268121000557
ThrombosisCOVID-19 vaccine-induced thrombosishttps://pubmed.ncbi.nlm.nih.gov/34802488/
ThrombosisCovid-19 vaccine-induced thrombosis and thrombocytopeniahttps://www.sciencedirect.com/science/article/abs/pii/S0033062021000505
ThrombosisCutaneous thrombosis associated with cutaneous necrosis following Oxford AstraZeneca COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34189756/
ThrombosisDeep venous thrombosis after vaccination with Ad2COVS in adult maleshttps://pubmed.ncbi.nlm.nih.gov/34659839/
ThrombosisDeep venous thrombosis more than two weeks after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/33928773/
ThrombosisDelayed headache after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34535076/
ThrombosisEndovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34782400/
ThrombosisFirst dose of ChAdOxand BNT162bCOVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotlandhttps://www.nature.com/articles/s41591-021-01408-4
ThrombosisGenital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNAhttps://pubmed.ncbi.nlm.nih.gov/34839563/
ThrombosisHypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-vaccinationhttps://www.sciencedirect.com/science/article/abs/pii/S0049384821003315
ThrombosisIdiopathic thrombocytopenic purpura and the Modern Covid-19 vaccinehttps://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext
ThrombosisImaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19 (AstraZeneca)https://pubmed.ncbi.nlm.nih.gov/34402666/
ThrombosisImmediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal veinhttps://pubmed.ncbi.nlm.nih.gov/34023956/
ThrombosisImmune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2https://www.sciencedirect.com/science/article/pii/S2214250921002018
ThrombosisImmune thrombocytopenia following Pfizer-BioNTech BNT162bmRNA COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34155844/
ThrombosisImmune thrombocytopenic purpura and acute liver injury after COVID-19 vaccinationhttps://casereports.bmj.com/content/14/7/e242678.
ThrombosisImmune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33987882/
ThrombosisImmunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34107198/
ThrombosisInflammation and platelet activation after COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34887867/
ThrombosisInformation on ChAdOxnCoV-19 vaccine-induced immune-mediated thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34587242/
ThrombosisIntracerebral haemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34402235/
ThrombosisIntracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOxnCOVID-19 vaccination in a pregnant womanhttps://pubmed.ncbi.nlm.nih.gov/34261297/
ThrombosisIschemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34035134/
ThrombosisLaboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34138513/
ThrombosisMajor artery thrombosis and vaccination against ChAdOxnCov-19https://pubmed.ncbi.nlm.nih.gov/34839830/
ThrombosisMalignant cerebral infarction after vaccination with ChAdOxnCov-19https://pubmed.ncbi.nlm.nih.gov/34341358/
ThrombosisManagement of a patient with a rare congenital limb malformation syndrome after SARS-CoV-vaccine-induced thrombosis and thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/34097311/
ThrombosisManagement of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca)https://pubmed.ncbi.nlm.nih.gov/33871350/
ThrombosisMechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-infectionhttps://www.sciencedirect.com/science/article/abs/pii/S0896841121000706
ThrombosisMultiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx(AstraZeneca), which required emergency femoral and carotid surgical thrombectomyhttps://pubmed.ncbi.nlm.nih.gov/34644642/
ThrombosisMyocardial infarction and azygos vein thrombosis after vaccination with ChAdOx nCoV-19 in a hemodialysis patienthttps://pubmed.ncbi.nlm.nih.gov/34650896/
ThrombosisNeuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34726934/
ThrombosisNew portal vein thrombosis in cirrhosishttps://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext
ThrombosisNewly diagnosed idiopathic thrombocytopenia after COVID-19 vaccine administrationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/
ThrombosisOccurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34876440/
ThrombosisPalmar digital vein thrombosis after Oxford-AstraZeneca COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34473841/
ThrombosisPFimmunoassays in vaccine-induced thrombotic thrombocytopeniahttps://www.nejm.org/doi/full/10.1056/NEJMc2106383
ThrombosisPlatelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × nCov-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34474550/
ThrombosisPortal vein thrombosis associated with ChAdOxnCov-19 vaccinehttps://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/
ThrombosisPortal vein thrombosis occurring after the first dose of SARS-CoV-mRNA vaccine in a patient with antiphospholipid syndromehttps://www.sciencedirect.com/science/article/pii/S2666572721000389
ThrombosisPossible triggers of thrombocytopenia and/or hemorrhage by BNT162bvaccine, Pfizer-BioNTechhttps://pubmed.ncbi.nlm.nih.gov/34660652/
ThrombosisPost-mortem findings in vaccine-induced thrombotic thrombocytopeniahttps://haematologica.org/article/view/haematol.2021.279075
ThrombosisPotential risk of thrombotic events after COVID-19 vaccination with Oxford AstraZeneca in women receiving estrogenhttps://pubmed.ncbi.nlm.nih.gov/34734086/
ThrombosisPredicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34254476/
ThrombosisPredictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34545400/
ThrombosisPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOxnCoV-19 vaccine (VITT)https://pubmed.ncbi.nlm.nih.gov/34256983/
ThrombosisPrimary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOxnCoV-19 vaccine (VITT)https://www.sciencedirect.com/science/article/pii/S0953620521002363
ThrombosisProcoagulant microparticleshttps://pubmed.ncbi.nlm.nih.gov/34129181/
ThrombosisProthrombotic immune thrombocytopenia after COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/pii/S0006497121009411
ThrombosisRare case of COVID-19 vaccine-associated intracranial hemorrhage with venous sinus thrombosishttps://pubmed.ncbi.nlm.nih.gov/34556531/
ThrombosisRefractory vaccine-induced immune thrombotic thrombocytopenia (VITT) treated with delayed therapeutic plasma exchange (TPE)https://pubmed.ncbi.nlm.nih.gov/34672380/
ThrombosisReport of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34462996/
ThrombosisRisk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-testshttps://pubmed.ncbi.nlm.nih.gov/34446426/
ThrombosisRoots of autoimmunity of thrombotic events after COVID-19 vaccinationhttps://www.sciencedirect.com/science/article/abs/pii/S1568997221002160
ThrombosisSecondary immune thrombocytopenia putatively attributable to COVID-19 vaccinationhttps://casereports.bmj.com/content/14/5/e242220.abstract.
ThrombosisSevere vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34355379/
ThrombosisShazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccinationhttps://www.ncbi.nlm.nih.gov/pubmed/34408937
ThrombosisThe roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopeniahttps://pubmed.ncbi.nlm.nih.gov/34455073/
ThrombosisThree cases of acute venous thromboembolism in women after coronavirus 2019 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34352418/
ThrombosisThree cases of acute venous thromboembolism in women after vaccination against COVID-19https://www.sciencedirect.com/science/article/pii/S2213333X21003929
ThrombosisThromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34132839/
ThrombosisThrombocytopenia after Pfizer and Moderna SARS vaccination – CoV -2https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/
ThrombosisThrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine”https://pubmed.ncbi.nlm.nih.gov/33918932/
ThrombosisThrombocytopenia and splanchnic thrombosis after vaccination with Ad2COVS successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomyhttps://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
ThrombosisThromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34264151/
ThrombosisThrombosis after adenovirus-vectored COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34755555/
ThrombosisThrombosis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34479129/
ThrombosisThrombosis and thrombocytopenia after vaccination with ChAdOxnCoV-19https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?
ThrombosisThrombosis and thrombocytopenia syndrome causing isolated symptomatic carotid occlusion after COVID-19 Ad2COVS vaccine (Janssen)https://pubmed.ncbi.nlm.nih.gov/34670287/
ThrombosisThrombosis formation after COVID-19 vaccination immunologic aspectshttps://pubmed.ncbi.nlm.nih.gov/34629931/
ThrombosisThrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34649281/
ThrombosisThrombosis in pre- and post-vaccination phase of COVID-19; httpshttps://pubmed.ncbi.nlm.nih.gov/34650382/
ThrombosisThrombosis with thrombocytopenia after Messenger vaccine RNA-1273https://pubmed.ncbi.nlm.nih.gov/34181446/
ThrombosisThrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOxnCoV-19 (AZD1222) COVID-19https://pubmed.ncbi.nlm.nih.gov/34272095/
ThrombosisThrombosis with thrombocytopenia syndrome after COVID-19 immunizationhttps://pubmed.ncbi.nlm.nih.gov/34236343/
ThrombosisThrombosis with thrombocytopenia syndrome associated with COVID-19 vaccineshttps://www.sciencedirect.com/science/article/abs/pii/S0735675721004381
ThrombosisThrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccineshttps://www.sciencedirect.com/science/article/abs/pii/S0953620521001904
ThrombosisThrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccineshttps://pubmed.ncbi.nlm.nih.gov/34835256/
ThrombosisThrombotic events after COVID-19 vaccination in over 50 years of agehttps://pubmed.ncbi.nlm.nih.gov/34835237/
ThrombosisThrombotic immune thrombocytopenia induced by SARS-CoV-vaccinehttps://www.nejm.org/doi/full/10.1056/nejme2106315
ThrombosisThrombotic thrombocytopenia after vaccination with ChAdOxnCov-19https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?
ThrombosisUnderstanding the risk of thrombosis with thrombocytopenia syndrome following Ad2COVS vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34595694/
ThrombosisUnusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19)https://pubmed.ncbi.nlm.nih.gov/34840204/
ThrombosisUS s of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad2COVS (against covid-19), March to April 21, 2020https://pubmed.ncbi.nlm.nih.gov/33929487/
ThrombosisVaccine-Associated Thrombocytopenia and Thrombosishttps://www.ncbi.nlm.nih.gov/pubmed/34833382
ThrombosisVaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34664303/
ThrombosisVaccine-induced immune thrombotic immune thrombocytopenia (VITT)https://pubmed.ncbi.nlm.nih.gov/33851389/
ThrombosisVaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhagehttps://pubmed.ncbi.nlm.nih.gov/34235757/
ThrombosisVaccine-induced thrombotic thrombocytopeniahttps://www.sciencedirect.com/science/article/pii/S2589936821000256
ThrombosisVaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemichttps://www.sciencedirect.com/science/article/pii/S0953620521002314
Thrombotic Thrombocytopenic PurpuraImmune thrombocytopenic purpura associated with COVID-19 mRNA vaccine Pfizer BioNTech BNT16B2b2https://pubmed.ncbi.nlm.nih.gov/34077572/
Thrombotic Thrombocytopenic PurpuraSevere immune thrombocytopenic purpura after SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34754937/
Thrombotic Thrombocytopenic PurpuraThrombotic thrombocytopenic purpurahttps://pubmed.ncbi.nlm.nih.gov/34264514/
Thrombotic Thrombocytopenic PurpuraThrombotic thrombocytopenic purpura after vaccination with Ad2COV2-Shttps://pubmed.ncbi.nlm.nih.gov/33980419/
Thymic hyperplasiaThymic hyperplasia after Covid-19 mRNA-based vaccination with Covid-19https://pubmed.ncbi.nlm.nih.gov/34462647/
ThyroiditisThree cases of subacute thyroiditis after SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34043800/
Tolosa-Hunt syndromeTolosa-Hunt syndrome occurring after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34513398/
Toxic Epidermal NecrolysisA case of toxic epidermal necrolysis after vaccination with ChAdOxnCoV-19 (AZD1222)https://pubmed.ncbi.nlm.nih.gov/34751429/
UrticariaIncreased risk of urticaria/angioedema after BNT162bmRNA COVID-19 vaccination in health care workers taking ACE inhibitorshttps://pubmed.ncbi.nlm.nih.gov/34579248/
UveitisBilateral uveitis after inoculation with COVID-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S1201971221007797
Varicella Zoster VirusAcute retinal necrosis due to varicella zoster virus reactivation after vaccination with BNT162bCOVID-19 mRNAhttps://pubmed.ncbi.nlm.nih.gov/34851795/
VasculitisA case of ANCA-associated vasculitis after AZD122(Oxford-AstraZeneca) SARS CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34416184/
VasculitisA case of generalized Sweet’s syndrome with vasculitis triggered by recent vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34849386/
VasculitisA case of leukocytoclastic vasculitis after vaccination with a SARS-CoVvaccinehttps://pubmed.ncbi.nlm.nih.gov/34196469/
VasculitisANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccinehttps://www.sciencedirect.com/science/article/pii/S0272638621007423
VasculitisAsymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophilshttps://pubmed.ncbi.nlm.nih.gov/34115904/
VasculitisCase of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019https://pubmed.ncbi.nlm.nih.gov/34535924/
VasculitisCOVID-19 vaccine-induced urticarial vasculitishttps://pubmed.ncbi.nlm.nih.gov/34369046/
VasculitisCutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34660867/
VasculitisCutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34327795
VasculitisCutaneous lymphocytic vasculitis after administration of the second dose of AZD122(Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus vaccinehttps://pubmed.ncbi.nlm.nih.gov/34726187/
VasculitisCutaneous small vessel vasculitis after COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34529877/
VasculitisCutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad2COVShttps://pubmed.ncbi.nlm.nih.gov/34337124/
VasculitisCutaneous vasculitis after severe acute respiratory syndrome coronavirus vaccinehttps://pubmed.ncbi.nlm.nih.gov/34557622/
VasculitisFirst description of immune complex vasculitis after COVID-19 vaccination with BNT162b2https://pubmed.ncbi.nlm.nih.gov/34530771/
VasculitisGranulomatous vasculitis after AstraZeneca anti-SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34237323/
VasculitisIgA vasculitis following COVID-19 vaccination in an adulthttps://pubmed.ncbi.nlm.nih.gov/34779011/
VasculitisIgA vasculitis in adult patient after vaccination with ChadOxnCoV-19https://pubmed.ncbi.nlm.nih.gov/34509658/
VasculitisImaging in vascular medicinehttps://pubmed.ncbi.nlm.nih.gov/34720009/
VasculitisInduction of cutaneous leukocytoclastic vasculitis after ChAdOxnCoV-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34853744/
VasculitisIntracerebral hemorrhage due to vasculitis following COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34783899/
VasculitisLeukocytoclastic vasculitis after coronavirus disease vaccination 2019https://pubmed.ncbi.nlm.nih.gov/34713472/803
VasculitisLeukocytoclastic vasculitis after exposure to COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34836739/
VasculitisLeukocytoclastic vasculitis as a cutaneous manifestation of ChAdOxcorona virus vaccine nCoV-19 (recombinant)https://pubmed.ncbi.nlm.nih.gov/34546608/
VasculitisNephrotic syndrome and vasculitis after SARS-CoV-vaccinehttps://pubmed.ncbi.nlm.nih.gov/34245294/
VasculitisNew-onset leukocytoclastic vasculitis after COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/34241833/
VasculitisOccurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19)https://pubmed.ncbi.nlm.nih.gov/34599716/
VasculitisOutbreak of leukocytoclastic vasculitis after COVID-19 vaccinehttps://pubmed.ncbi.nlm.nih.gov/33928638/
VasculitisOutbreaks of mixed cryoglobulinemia vasculitis after vaccination against SARS CoV-2https://pubmed.ncbi.nlm.nih.gov/34819272/
VasculitisPossible case of COVID-19 mRNA vaccine-induced small-vessel vasculitishttps://pubmed.ncbi.nlm.nih.gov/34705320/
VasculitisPropylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis following vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34451967/
VasculitisReactivation of IgA vasculitis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34250509/
VasculitisReactivation of IgA vasculitis after vaccination with COVID-19https://pubmed.ncbi.nlm.nih.gov/34848431/
VasculitisRelapse of microscopic polyangiitis after COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34251683/
VasculitisSmall-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS CoV-2https://pubmed.ncbi.nlm.nih.gov/34310763/
VasculitisVaricella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34310759/
VasculitisVasculitis and bursitis in [ 1F] FDG-PET/CT after COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34495381/
Vesiculobullous cutaneous reactionsVesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccinehttps://pubmed.ncbi.nlm.nih.gov/34236711/
Vogt-Koyanagi-Harada syndromeReactivation of Vogt-Koyanagi-Harada disease under control for more than years, after anti-SARS-CoV-vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34224024/
Vogt-Koyanagi-Harada syndromeVogt-Koyanagi-Harada syndrome after COVID-19 and ChAdOxnCoV-19 (AZD1222) vaccinationhttps://pubmed.ncbi.nlm.nih.gov/34462013/
V-REPP vaccine-related eruption of papules and plaques.Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V REPPhttps://www.sciencedirect.com/science/article/pii/S0190962221024427

By Dr. Dannielle (Dossy) Blumenthal. All opinions are the author’s own. Public domain.

%d bloggers like this: